AU Patent

AU2003211560A1 — Novel phenylalanine derivative

Assigned to Ajinomoto Co Inc · Expires 2003-09-09 · 23y expired

What this patent protects

The present invention relates to the following phenylalanine derivatives or analogues thereof having an antagonistic activity to alpha 4 integrin and therapeutic agents for various diseases concerning alpha 4 integrin. <CHEM>

USPTO Abstract

The present invention relates to the following phenylalanine derivatives or analogues thereof having an antagonistic activity to alpha 4 integrin and therapeutic agents for various diseases concerning alpha 4 integrin. <CHEM>

Drugs covered by this patent

Patent Metadata

Patent number
AU2003211560A1
Jurisdiction
AU
Classification
—
Expires
2003-09-09
Drug substance claim
No
Drug product claim
No
Assignee
Ajinomoto Co Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.